Pseudoexfoliation syndrome
<p>Monitoring and management of the patient with pseudoexfoliation syndrome: current perspectives</p>
12
Role of zonular assessment by ultrasound biomicroscopy before cataract surgery in pseudoexfoliation syndrome towards ensuring satisfactory PCIOL implantation
104
Analytical study of pseudoexfoliation syndrome, its association with glaucoma and its surgical complications
142
Assessment of Pupil Diameters in Pseudoexfoliation Syndrome under Scotopic, Mesopic, Photopic and Dynamic Conditions Using Infrared Pupillometer (Assessment of Pupil Diameters in Pseudoexfoliation Syndrome)
7
Central corneal thickness in subjects with glaucoma and in normal individuals (with or without pseudoexfoliation syndrome)
6
The prevalence of pseudoexfoliation syndrome in Pakistan. Hospital based study
5
Cataract surgery in patients with pseudoexfoliation syndrome: current updates
7
Central retinal vein occlusion and pseudoexfoliation syndrome
5
Tissue inhibitor of metalloproteinase 4 in aqueous humor of patients with primary open angle glaucoma, pseudoexfoliation syndrome and pseudoexfoliative glaucoma and its role in proteolysis imbalance
7
Evaluation of the anterior chamber angle in pseudoexfoliation syndrome
7
Clinical study of glaucoma in pseudoexfoliation syndrome
83
Pseudoexfoliation syndrome at a Singapore eye clinic
6
Prevalence of Pseudoexfoliation Syndrome and Pseudoexfoliation Glaucoma in Upper Egypt
6
Ocular Profile of Patients with Pseudoexfoliation Syndrome and Pseudoexfoliation Glaucoma
5
Pseudoexfoliation syndrome, a systemic disorder with ocular manifestations
10
<p>Surgical experience with a redesigned, fully preloaded, hydrophobic acrylic intraocular lens in challenging cases of pseudoexfoliation syndrome, phacodonesis, and small pupils</p>
8
Risk factors for corneal endothelial cell loss by cataract surgery in eyes with pseudoexfoliation syndrome
5
Lysyl oxidase-like 1 polymorphisms in a southwestern Greek cataract population with pseudoexfoliation syndrome
6
Matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2, and transforming growth factor beta 1 in the aqueous humor and serum of patients with pseudoexfoliation syndrome
5
Outcome of Phacoemulsification in patients with and without Pseudoexfoliation syndrome in Kashmir
5